Tags: moderna earnings | covid vaccine

Moderna Meets Forecast With $18.4B in COVID Vax Sales

Moderna Meets Forecast With $18.4B in COVID Vax Sales
(AP)

Monday, 09 January 2023 07:37 AM EST

Moderna Inc. said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022, meeting its forecast of $18 billion-$19 billion for the year.

The company also forecast minimum COVID-19 vaccine sales of about $5 billion in 2023, compared with its previous forecast of $4.5 billion to $5.5 billion in November.

The COVID vaccine maker continues to expect additional contracts for 2023, it said.

© 2026 Thomson/Reuters. All rights reserved.


StreetTalk
Moderna Inc. said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022, meeting its forecast of $18 billion-$19 billion for the year.
moderna earnings, covid vaccine
66
2023-37-09
Monday, 09 January 2023 07:37 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved